The effects of combined arachidonic acid and docosahexaenoic acid supplementation in preterm infants: A protocol for a systematic review and meta-analysis of clinical trials
Prostaglandins, Leukotrienes and Essential Fatty Acids · 2026-12 · 211 · 102780
DOI: 10.1016/j.plefa.2026.102780 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Prostaglandins, Leukotrienes and Essential Fatty Acids, 2026-12. Verfasst von Jacqueline Chan und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Health Sciences, University of Roehampton, Holybourne Avenue, London, SW154JD, United Kingdom. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Waterloo Foundation.
Themen: Neonatologie
Abstract (Originalsprache)
BACKGROUND: The third trimester is the period of maximal brain growth and fat deposition, and current clinical practices may not provide sufficient levels of the long-chain polyunsaturated fatty acids (PUFA), arachidonic acid (ARA) and docosahexaenoic acid (DHA), to match those provided in utero leading to a phenomenon we call the Preterm PUFA Gap. The balance and levels of ARA and DHA provided are critical for developmental outcomes; however, clinical trials have generally focused on DHA-only interventions and subsequently produce mixed or negative outcomes. Therefore, we will investigate the effect of more physiologically appropriate combined ARA and DHA interventions on clinical outcomes in preterm infants. METHODS: We will conduct a systematic review and meta-analysis of clinical trials evaluating the effect of enteral supplementation of both ARA and DHA, compared with standard feeding, in preterm infants born
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life and Health Sciences, University of Roehampton, Holybourne Avenue, London, SW154JD, United Kingdom.
- School of Life and Health Sciences, University of Roehampton, Holybourne Avenue, London, SW154JD, United Kingdom. Electronic address: simon.dyall@roehampton.ac.uk.
Förderung
- Waterloo Foundation
Zitieren
APA
Chan, J., Elbagir, M., & Dyall, S. C. (2026). The effects of combined arachidonic acid and docosahexaenoic acid supplementation in preterm infants: A protocol for a systematic review and meta-analysis of clinical trials. Prostaglandins, Leukotrienes and Essential Fatty Acids, 211, 102780. https://doi.org/10.1016/j.plefa.2026.102780
Vancouver
Chan J, Elbagir M, Dyall SC. The effects of combined arachidonic acid and docosahexaenoic acid supplementation in preterm infants: A protocol for a systematic review and meta-analysis of clinical trials. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2026;211:102780. doi:10.1016/j.plefa.2026.102780
BibTeX
@article{Chan2026,
author = {Chan, Jacqueline and Elbagir, Mram and Dyall, Simon C},
title = {The effects of combined arachidonic acid and docosahexaenoic acid supplementation in preterm infants: A protocol for a systematic review and meta-analysis of clinical trials},
journal = {Prostaglandins, Leukotrienes and Essential Fatty Acids},
year = {2026},
volume = {211},
pages = {102780},
doi = {10.1016/j.plefa.2026.102780}
}
EUVIMED